ENANTA PHARMACEUTICALS INC·4

Aug 8, 4:35 PM ET

Rottinghaus Scott T. 4

4 · ENANTA PHARMACEUTICALS INC · Filed Aug 8, 2025

Insider Transaction Report

Form 4
Period: 2025-08-08
Rottinghaus Scott T.
Chief Medical Officer
Transactions
  • Tax Payment

    Common Stock

    2025-08-08$6.99/sh2,217$15,49722,590 total
Footnotes (1)
  • [F1]Represents the number of shares of ENTA common stock forfeited by the reporting person to cover withholding taxes due as a result of settlement of a portion of the restricted stock unit award granted on August 8, 2022.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES